The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Semaglutide: a game changer for metabolic diseases?”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Qing Yang, Chunmei Qin, Yanlin Lang, Wenjie Yang, Fenghao Yang, Jia Yang, Ke Liu, Jiamin Yuan, Yutong Zou, Fang Liu. Effectiveness of Sodium-Glucose Transporter 2 Inhibitors and Semaglutide on Body Composition in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Real-World Cohort Study with Bioelectrical Impedance Analysis, Diabetes, Metabolic Syndrome and Obesity. 2025; Volume 18: 2885. https://doi.org/10.2147/DMSO.S531413 |
|
2 |
2023 |
Lucia Manuella, Laura Sciacca. Efficacia e sicurezza di Tirzepatide per il trattamento di soggetti affetti da obesità e sovrappeso, L'Endocrinologo. 2023; 24: 95. https://doi.org/10.1007/s40619-023-01221-w |
|
3 |
2024 |
Agostino Milluzzo, Lucia Manuella, Lucia Frittitta, Laura Sciacca. Efficacy of a phone reminder to improve adherence to post-partum glucose tolerance testing after gestational diabetes and clinical predictors of post-partum follow-up compliance, Diabetes Research and Clinical Practice. 2024; 210: 111653111653. https://doi.org/10.1016/j.diabres.2024.111653 |
|
4 |
2025 |
Christoffer Kraul Ibsen, Marius Brostrøm Kousgaard, Sofie Olsen, Ann-Kathrin Lindahl Christiansen, Catharina Thiel Sandholdt, Rasmus Rørth, Gritt Overbeck. Patients’ experiences with GLP1-RAs – a systematic review, Scandinavian Journal of Primary Health Care. 2025; 43: 370. https://doi.org/10.1080/02813432.2025.2477141 |